Aktienanalyse wird geladen …
GEHC · NASDAQ · Medical Devices · USA
66,09 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 20,63 Mrd. | 2,08 Mrd. | 4,55 $ | 458 Mio. | 2 Mio · 0,4 % | 3 Mio · 0,6 % | 40 % | 10,1 % | 3,29 $ | 0,28 $ | 0,14 $ |
| 2024 | 19,67 Mrd. | 1,99 Mrd. | 4,34 $ | 459 Mio. | 1,9 Mio · 0,4 % | 0,9 Mio · 0,2 % | 41,7 % | 10,1 % | 3,39 $ | 0,27 $ | 0,13 $ |
| 2023 | 19,55 Mrd. | 1,57 Mrd. | 3,03 $ | 458 Mio. | 1,7 Mio · 0,4 % | — | 40,5 % | 8 % | 3,74 $ | 0,25 $ | 0,12 $ |
| 2022 | 18,34 Mrd. | 1,92 Mrd. | 4,22 $ | 454 Mio. | 1 Mio · 0,2 % | 1 Mio · 0,2 % | 39,1 % | 10,5 % | 4,02 $ | 0,15 $ | 0,00 $ |
| 2021 | 17,59 Mrd. | 2,25 Mrd. | 4,95 $ | 454 Mio. | 1,1 Mio · 0,3 % | 1,9 Mio · 0,4 % | 40,8 % | 12,8 % | 2,99 $ | 0,17 $ | 0,00 $ |
| 2020 | 17,16 Mrd. | 13,85 Mrd. | 30,45 $ | 454,71 Mio. | — | — | 39,4 % | 80,7 % | 3,14 $ | — | — |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 5,13 Mrd. | 389 Mio. | 0,85 $ | 457 Mio. | 38,5 % | 7,6 % | 0,25 $ |
| Q4 2025 | 5,7 Mrd. | 588 Mio. | 1,28 $ | 457 Mio. | 39,7 % | 10,3 % | 2,00 $ |
| Q3 2025 | 5,14 Mrd. | 446 Mio. | 0,98 $ | 457 Mio. | 38,7 % | 8,7 % | 1,81 $ |
| Q2 2025 | 5,01 Mrd. | 486 Mio. | 1,06 $ | 458 Mio. | 39,6 % | 9,7 % | 0,02 $ |
| Q1 2025 | 4,78 Mrd. | 564 Mio. | 1,23 $ | 459 Mio. | 42,1 % | 11,8 % | 0,21 $ |
| Q4 2024 | 5,32 Mrd. | 721 Mio. | 1,57 $ | — | 42,8 % | 13,6 % | 1,77 $ |
| Q3 2024 | 4,86 Mrd. | 470 Mio. | 1,02 $ | 459 Mio. | 41,7 % | 9,7 % | 2,07 $ |
| Q2 2024 | 4,84 Mrd. | 428 Mio. | 0,93 $ | 459 Mio. | 41,4 % | 8,8 % | -0,40 $ |
GE HealthCare (GEHC) is Down 28% and Wall Street is Starting to Buy. Is the Selloff Finally Over?
GE Healthcare Appoints AT&T CFO Pascal Desroches to Board
GE HealthCare announces cash dividend increase for third quarter of 2026
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
GEHC Could Be Set For A Turnaround — Needham Sees 44% Upside For GE Healthcare After Nearly 21% YTD Slide
Needham Initiates GE Healthcare Technologies at Buy With $93 Price Target
Is GE HealthCare Technologies (GEHC) Undervalued On Its CareIntellect AI Launch?
GE HealthCare Technologies Inc. is a global medical technology and diagnostics company that develops imaging systems, ultrasound equipment, patient monitoring and anesthesia solutions, and pharmaceutical diagnostics products. Its portfolio supports hospitals, health systems, and clinical providers with tools used in diagnosis, treatment, and patient care across routine and complex medical settings. GE HealthCare also offers software, digital workflows, and service capabilities that help healthcare organizations manage equipment, improve clinical efficiency, and integrate data across care environments. The company’s main business areas include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, reflecting its broad role in modern healthcare infrastructure. Headquartered in Chicago, Illinois, GE HealthCare focuses on technologies and services that are widely used in medical imaging, bedside monitoring, and diagnostic procedures worldwide.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest GEHC und jede andere Aktie unbegrenzt.